US compliance experts interpret the '1022 electronic cigarette seizure incident': if you want to stay in the US market, you must submit a PMTA application

US compliance experts interpret the '1022 electronic cigarette seizure incident': if you want to stay in the US market, you must submit a PMTA application

After joint law enforcement efforts by multiple departments in the United States seized approximately 3 million illegal electronic cigarettes, 2Firsts contacted Tom Beaudet, CEO of American compliance company Accor. He interpreted the background of this enforcement, predicted future trends, and provided response strategies for companies' compliance in the United States. At the compliance seminar organized by 2Firsts in August, Tom predicted that the United States would increase its enforcement efforts against illegal electronic cigarettes. The occurrence of this incident confirms this prediction.

The US Food and Drug Administration (FDA) recently announced the seizure of approximately 3 million illegal electronic cigarette products with an estimated retail value of $76 million, making it one of the largest enforcement actions by the FDA to date. This operation, carried out in collaboration between the FDA and the U.S. Customs and Border Protection (CBP), marks a further escalation of the U.S. efforts to prevent illegal electronic cigarette products from entering the country. Given this significant enforcement measure, 2Firsts interviewed Tom Beaudet, CEO of Accor, to understand the compliance challenges and market changes facing the e-cigarette industry.

In interviews and multiple conversations at the "New Tobacco Regulatory Policies and Compliance Development Seminar for the US Market" hosted by 2Firsts in Shenzhen in August this year, Beaudet warned that the FDA's regulation of electronic cigarette products, especially those with flavors, is constantly tightening. He predicts that companies that fail to meet strict PMTA (Pre Market Application for Tobacco Products) standards will face significant obstacles, which also means that non compliant products may be withdrawn from the market. The FDA's large-scale seizure of illegal electronic cigarette products confirms its prediction.

In this interview, Tom Beaudet focused on interpreting the recent actions of the FDA and their broader impact on the industry, including:

Strengthening Enforcement: The collaboration between FDA and CBP has established new standards for tracking and clearing non compliant products.
The importance of PMTA compliance: As enforcement actions will be further strengthened, if a company wishes to remain in the market, it must submit a comprehensive compliance PMTA application.

Reducing compliance costs through "bridging": Enterprises can lower PMTA compliance costs by "bridging" applications to approved products, thereby reducing the need for expensive long-term research such as pharmacokinetic studies and conversion efficacy testing.

Cross border trade compliance challenges: The new compliance requirements of FDA and CBP pose significant challenges for international companies to avoid non-compliance situations, requiring them to maintain updated information and adapt quickly.

PMTA compliance focus areas: Key compliance processes include chemical analysis, toxicological risk assessment, long-term stability testing, and cancer risk assessment.

To cope with the continuous strengthening of law enforcement: With the increase of regulatory efforts, in order to avoid the risks of high fines and restricted market access, enterprises must establish a sound compliance management system.

2Firsts interviewed three compliance experts at a seminar held in Shenzhen in August this year, with Tom Beaudet on the far right| Image source: 2Firsts

On August 26, 2024, the "Seminar on New Tobacco Regulatory Policies and Compliance Development in the US Market" hosted by Two Up First was successfully held in Shenzhen| Image source: 2Firsts